[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353134-105":59,"doc-detail-353134-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-nomogram-predicting-survival-in-resectable-gallbladder-cancer","Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer","","Gallbladder cancers (GBCs) are aggressive malignancies with limited survival improvements over decades, making accurate prognosis essential for individualized care. This study develops a nomogram to predict overall survival in patients with resectable GBCs and performs internal validation. A retrospective cohort of 1045 resected cases (2010–2022) was analyzed, yielding a model that stratifies patients by risk score and estimates time-specific OS.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-nomogram-predicting-survival-in-resectable-gallbladder-cancer/353134/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-nomogram-predicting-survival-in-resectable-gallbladder-cancer/353134.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of this study?","Question",{"text":112,"@type":113},"To develop and validate a nomogram predicting overall survival in patients with resectable gallbladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the nomogram developed and validated?",{"text":117,"@type":113},"Using a retrospective analysis of 1045 resected GBC patients (2010–2022), with internal validation of the predictive nomogram.",{"name":119,"@type":110,"acceptedAnswer":120},"What variables were included in the nomogram?",{"text":121,"@type":113},"Age, original T and N stage, lympho-vascular/perineural invasion, CA 19.9, incidental vs non-incidental GBC, and tumor grade.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353134,1790448911,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":138,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":139,"faqs":140,"seo_title":141,"seo_description":67,"update_tm":142,"read_time":143,"preview_page_count":19,"preview_urls":144},4398046744996,"Journal of Hepato-Biliary-Pancreatic Sciences  \n ORIGINAL ARTICLE  OPEN ACCESS   \nDevelopment and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer  \nShraddha Patkar1 | Tanvi M. Shah1  | Mufaddal Kazi1 | Sadhana Kannan2 | Gurudutt Varty1 | Vikas Ostwal3  | Anant Ramaswamy3 | Prabhat Bhargav3  | Prajakta Barve1 | Mahesh Goel1   \n1Department of Surgical Oncology, Tata Memorial Hospital and Homi Bhabha National Institution, Mumbai, India | 2Department of Biostatistics, Advanced Centre for Treatment, Research and Education (ACTREC), Navi Mumbai, India | 3Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India  \nCorrespondence: Mahesh Goel ([drmaheshgoel@gmail.com](drmaheshgoel@gmail.com))  \nReceived: 17 October 2025 | Revised: 22 March 2026 | Accepted: 30 March 2026  \nKeywords: adjuvant treatment selection | gallbladder cancer survival | predictive nomogram  \nABSTRACT  \nBackground: Gallbladder cancers (GBCs) are aggressive tumors with limited improvement in outcomes over decades. Accurate prediction of survival is crucial for tailored treatment and improved outcomes.  \nObjective: To develop a nomogram predicting overall survival (OS) in resectable GBCs.  \nMethods: A retrospective analysis of 1045 patients of resected gallbladder cancer between January 2010 to December 2022 was done. A predictive nomogram was built and was internally validated.  \nResults: The nomogram included age, original T stage, original N stage, and lympho-vascular/perineural invasion, CA 19.9, incidental versus non-incidental GBC, and grade. The Harrell's concordance index for the nomogram was 0.677. The area under the ROC curves for 1-, 3-, and 5-year OS were 72.12, 72.64, and 71.15 respectively. Patients were stratified into low-risk and highrisk groups based on a threshold score of 22.48, with significantly different median OS (not reached vs. 31.4 months, p \u003C 0.001) . Conclusions: The developed nomogram demonstrates good discriminative capacity and risk stratification in patients undergoing surgery for GBC and may be utilized for better selection and application of adjuvant treatment strategies, potentially improving outcomes.  \n1 | Introduction  \nGallbladder cancers (GBCs) are aggressive tumors with very little improvement realized in the outcomes over decades. Traditionally, the reported 5-year overall survival (OS) after curative resections is only 20%–30%[1] and has largely remained dismal over decades [2] . Adjuvant and neoadjuvant therapies have been shown to improve outcomes; with 3-year OS reported in one large series to be 94.1%, 82.6%, and 48.2% for Stage I, II, and III respectively [3]. The published evidence is heterogenous in terms of indications and protocols, and often GBCs are included within the broad spectrum ofbiliary tract cancers (BTCs)[4–6]. As GBCs represent a very distinct clinical entity differing from other sub-sites of BTCs in terms of chemosensitivity and  \nradiosensitivity and the surgical approaches, it is imperative to develop tools which can accurately predict the survival and risk of recurrence in an individual patient, thereby guiding precise and tailored treatment, with an aim to improve long-term outcomes. The present study aims to develop and validate a nomogram predicting OS in patients with GBCs undergoing curative treatment, which can be used as objective tools for supplementing clinical decision making.  \n2 | Methods  \nThe study follows a retrospective observational cohort design. A prospectively maintained database of patients operated for GBCs  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-BiliaryPancreatic Surgery.  \n454 Journal of Hepato-Biliary-Pancreatic Sciences","cbCaipHJXLCGtrEz","https://ap.wps.com/l/cbCaipHJXLCGtrEz","pdf",1411646,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What was the main objective of this study?\",\"answer\":\"To develop and validate a nomogram predicting overall survival in patients with resectable gallbladder cancer.\"},{\"question\":\"How was the nomogram developed and validated?\",\"answer\":\"Using a retrospective analysis of 1045 resected GBC patients (2010–2022), with internal validation of the predictive nomogram.\"},{\"question\":\"What variables were included in the nomogram?\",\"answer\":\"Age, original T and N stage, lympho-vascular/perineural invasion, CA 19.9, incidental vs non-incidental GBC, and tumor grade.\"}]","Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer | PDF",1790103224,23,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c47bc9ca1438370bf7741450a62d1fcc.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0673453b3bf6d402488a35e1ca173fc.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be716bb58f1709702fcb9c524acddc52.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0c828918b76898bba0fd245ce507ed8.webp",980,1287]